CAPTRUST FINANCIAL ADVISORS - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$7,000
-41.7%
2,783
-7.2%
0.00%
Q2 2021$12,000
-14.3%
2,999
-3.4%
0.00%
Q1 2021$14,0003,1050.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 3,661,237$8,970,0000.44%
Alpine Global Management, LLC 370,000$907,0000.21%
DELTEC ASSET MANAGEMENT LLC 460,500$1,128,0000.17%
IHT Wealth Management, LLC 334,367$819,0000.07%
Redmile Group, LLC 1,358,825$3,329,0000.06%
GPS Wealth Strategies Group, LLC 58,025$142,0000.04%
Granahan Investment Management 465,049$1,139,0000.02%
SEARLE & CO. 20,000$49,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 402,300$986,0000.02%
Gladstone Institutional Advisory LLC 53,500$1310.01%
View complete list of XERIS PHARMACEUTICALS INC shareholders